Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuo Nagano

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 15, 2008
[Pharmacological and clinical profiles of long-lasting erythropoiesis-stimulating agent (darbepoetin alfa; NESP]Nobuo Nagano
Pharmacology & Therapeutics|August 17, 2005
Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidismNobuo Nagano
Clinical and Experimental Nephrology|May 1, 2021
Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effectsNobuo Nagano
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 3, 2023
[Drug discovery related to zinc]Nobuo Nagano
Clinical Calcium|January 6, 2005
[Drugs inhibiting parathyroid hormone (PTH) secretion by control of the calcium receptor (calcimimetics)--effect on the set point of calcium-regulated PTH secretion]Nobuo Nagano
Clinical Calcium|January 8, 2008
[Basic and clinical aspects of calcimimetics. Discovery and development of calcimimetics]Nobuo Nagano
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 5, 2006
[Calcium receptor/calcium-sensing receptor]Nobuo Nagano
Clinical Calcium|December 4, 2004
[Sevelamer hydrochloride prevents ectopic calcification of blood vessels]Naoshi Fukushima, Nobuo Nagano
Clinical Calcium|November 8, 2005
[The calcium receptor and magnesium metabolism]Takehisa Kawata, Nobuo Nagano
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2003
Control of parathyroid cell growth by calcimimeticsMichihito Wada, Nobuo Nagano
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|April 15, 2008
[Pharmacological and clinical profiles of long-lasting erythropoiesis-stimulating agent (darbepoetin alfa; NESP]Nobuo Nagano
Pharmacology & Therapeutics|August 17, 2005
Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidismNobuo Nagano
Clinical and Experimental Nephrology|May 1, 2021
Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effectsNobuo Nagano
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 3, 2023
[Drug discovery related to zinc]Nobuo Nagano
Clinical Calcium|January 6, 2005
[Drugs inhibiting parathyroid hormone (PTH) secretion by control of the calcium receptor (calcimimetics)--effect on the set point of calcium-regulated PTH secretion]Nobuo Nagano
Clinical Calcium|January 8, 2008
[Basic and clinical aspects of calcimimetics. Discovery and development of calcimimetics]Nobuo Nagano
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 5, 2006
[Calcium receptor/calcium-sensing receptor]Nobuo Nagano
Clinical Calcium|December 4, 2004
[Sevelamer hydrochloride prevents ectopic calcification of blood vessels]Naoshi Fukushima, Nobuo Nagano
Clinical Calcium|November 8, 2005
[The calcium receptor and magnesium metabolism]Takehisa Kawata, Nobuo Nagano
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 29, 2003
Control of parathyroid cell growth by calcimimeticsMichihito Wada, Nobuo Nagano
Pageof 5